Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11267801 Therapeutic compounds

Patent 11267801 was granted and assigned to Gilead Sciences on March, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Gilead Sciences

Current Assignee

Gilead Sciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Winston C. Tse0

Chienhung Chou0

Eda Canales0

Gediminas Brizgys0

Jennifer R. Zhang0

Jiayao Li0

Michael Graupe0

Qiaoyin Wu0

...

Date of Patent

March 8, 2022

Patent Application Number

17062676

Date Filed

October 5, 2020

Patent Citations

US Patent 10696657 Methods and intermediates for preparing therapeutic compounds

US Patent 10836746 Therapeutic compounds

0

US Patent 11117886 Methods and intermediates for preparing therapeutic compounds

0

US Patent 10849892 Choline salt forms of an HIV capsid inhibitor

US Patent 10071985 Therapeutic compounds

US Patent 10370342 Toll like receptor modulator compounds

0

US Patent 10370358 Compounds for the treatment of HIV

US Patent 10640499 Toll like receptor modulator compounds

0

...

Patent Citations Received

US Patent 12084467 Therapeutic compounds for HIV virus infection

0

US Patent 11787825 Therapeutic compounds for HIV virus infection

Patent Primary Examiner

Patent abstract

The invention provides compounds having Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11267801 Therapeutic compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool